Fundraising Fox
/Companies
Sign in

Tessera

191 employees on LinkedIn · 12 known investors

Find your way into Tessera

Sign up to see every warm intro you have to Tessera

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tessera team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.

BiotechDigital HealthMedical Devices

Founders & leadership

GVGeoff von Maltzahn
Geoff von MaltzahnFounding CEO, Chairman of BoardGeoff von Maltzahn is founder and CEO of Tessera Therapeutics, a company developing Gene Writing technology for genome engineering. He previously served as CTO of Seres Therapeutics and has founded or led multiple biotechnology companies including Generate:Biomedicines, Indigo Agriculture, and Kaleido Biosciences.
JRJoseph Romanelli
Joseph RomanelliCEO
GV
Geoffrey von MaltzahnFounder
JR
Jacob RubensFounder
NA
Noubar AfeyanFounder
RC
Rob CitorikFounder

Investors · 12

Flagship Pioneeringlisted by Flagship PioneeringCambridge · $500K – $10M

How we know: Flagship Pioneering's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

March Capital Partnerslisted by March Capital PartnersSanta Monica

How we know: March Capital Partners's portfolio page · the VCSheet dataset · Not right? Tell us

OMX Ventureslisted by OMX VenturesLincolnshire

How we know: the VCSheet dataset · Not right? Tell us

SoftBank Vision Fundlisted by SoftBank Vision FundLondon
Solari Capitallisted by Solari CapitalNew York
Toba Capitallisted by Toba CapitalLos Angeles · $1M – $10M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Altitude Ventures Management, LlcreportedKirkland

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Andreessen HorowitzreportedMenlo Park · $500K – $50M

How we know: funding news · press coverage · Not right? Tell us

Foresite CapitalreportedWest Hollywood

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Foundation CapitalreportedPalo Alto · $250K – $15M

How we know: press coverage · Not right? Tell us

Myriad Venture Partnersreported

How we know: press coverage · Not right? Tell us

Founder mafia

3 people who came through Tessera went on to found or lead other companies.

Noubar AfeyanCo-Founder and Board MemberFounded ProFound Therapeutics +15Geoffrey von MaltzahnFounderFounded Sienna Biopharmaceuticals +4Sakshi Chhabra MittalInvestorFounded Foodhak

Frequently asked questions

What does Tessera do?
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.
Who founded Tessera?
Tessera was founded by Geoff von Maltzahn.
Who are Tessera's investors?
Tessera's investors include Artis Ventures, Flagship Pioneering, March Capital Partners, OMX Ventures, SoftBank Vision Fund, Solari Capital, Toba Capital, Altitude Ventures Management, Llc and 4 more.